Literature DB >> 10889804

The Finnish Diabetes Prevention Study.

M Uusitupa1, A Louheranta, J Lindström, T Valle, J Sundvall, J Eriksson, J Tuomilehto.   

Abstract

The aim of the Finnish Diabetes Prevention Study is to assess the efficacy of an intensive diet-exercise programme in preventing or delaying type 2 diabetes in individuals with impaired glucose tolerance (IGT) and to evaluate the effect of the programme on the risk factors of atherosclerotic vascular diseases and the incidence of cardiovascular events. In this ongoing study, a total of 523 overweight subjects with IGT based on two oral glucose tolerance tests were randomized to either an intervention group or a control group. The main measure in the intervention group is individual dietary advice aimed at reducing weight and intake of saturated fat and increasing intake of dietary fibre. The intervention subjects are individually guided to increase their level of physical activity. The control group receives general information about the benefits of weight reduction, physical activity and healthy diet in the prevention of diabetes. A pilot study began in 1993, and recruitment ended in 1998. By the end of April 1999 there were 65 new cases of diabetes, 34 drop-outs and one death. The weight reduction was greater (-4.6 kg) at 1 year in the intervention group (n = 152) than in the control group (n = 143, -0.9 kg, P < 0.0001), and this difference was sustained in the second year of follow-up. At 1 year 43.4% and at 2 years 41.8% of the intervention subjects had achieved a weight reduction of at least 5 kg, while the corresponding figures for the control subjects were 14.0 and 12.0% (P < 0.001 between the groups). At 1 year the intervention group showed significantly greater reductions in 2 h glucose, fasting and 2 h insulin, systolic and diastolic blood pressure, and serum triglycerides. Most of the beneficial changes in cardiovascular risk factors were sustained for 2 years. These interim results of the ongoing Finnish Diabetes Prevention Study demonstrate the efficacy and feasibility of the lifestyle intervention programme.

Entities:  

Mesh:

Year:  2000        PMID: 10889804     DOI: 10.1017/s0007114500001070

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  30 in total

Review 1.  The major diabetes prevention trials.

Authors:  Jaakko Tuomilehto; Jaana Lindström
Journal:  Curr Diab Rep       Date:  2003-04       Impact factor: 4.810

2.  Family networks of obesity and type 2 diabetes in rural Appalachia.

Authors:  Petr Pancoska; Shama Buch; Alfred Cecchetti; Bambang Parmanto; Marcella Vecchio; Stephen Groark; Stephanie Paulsen; Genevieve Bardwell; Cathy Morton; Ann Chester; Robert Branch
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

Review 3.  Reduced or modified dietary fat for preventing cardiovascular disease.

Authors:  Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen J Moore; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

4.  2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.

Authors:  Michael D Jensen; Donna H Ryan; Caroline M Apovian; Jamy D Ard; Anthony G Comuzzie; Karen A Donato; Frank B Hu; Van S Hubbard; John M Jakicic; Robert F Kushner; Catherine M Loria; Barbara E Millen; Cathy A Nonas; F Xavier Pi-Sunyer; June Stevens; Victor J Stevens; Thomas A Wadden; Bruce M Wolfe; Susan Z Yanovski; Harmon S Jordan; Karima A Kendall; Linda J Lux; Roycelynn Mentor-Marcel; Laura C Morgan; Michael G Trisolini; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

Review 5.  Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

Authors:  Lara C Morley; Thomas Tang; Ephia Yasmin; Robert J Norman; Adam H Balen
Journal:  Cochrane Database Syst Rev       Date:  2017-11-29

6.  Diabetes Mellitus: A Local and Global Public Health Emergency!

Authors:  Jawad A Al-Lawati
Journal:  Oman Med J       Date:  2017-05

7.  Glucose metabolism among residents in Shanghai: natural outcome of a 5-year follow-up study.

Authors:  Q Qian; X Li; X Huang; M Fu; Z Meng; M Chen; B Feng
Journal:  J Endocrinol Invest       Date:  2011-07-07       Impact factor: 4.256

8.  The transitioning from trials to extended follow-up studies.

Authors:  Lea T Drye; Anne S Casper; Alice L Sternberg; Janet T Holbrook; Gabrielle Jenkins; Curtis L Meinert
Journal:  Clin Trials       Date:  2014-08-12       Impact factor: 2.486

Review 9.  Obesity and sedentary lifestyle: modifiable risk factors for prevention of type 2 diabetes.

Authors:  E J Mayer-Davis; T Costacou
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

10.  Variation in the UCP2 and UCP3 genes associates with abdominal obesity and serum lipids: the Finnish Diabetes Prevention Study.

Authors:  Titta Salopuro; Leena Pulkkinen; Jaana Lindström; Marjukka Kolehmainen; Anna-Maija Tolppanen; Johan G Eriksson; Timo T Valle; Sirkka Aunola; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Jaakko Tuomilehto; Markku Laakso; Matti Uusitupa
Journal:  BMC Med Genet       Date:  2009-09-21       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.